Lonza opens largest gene therapy plant in the world and hires 200 scientists

Switzerland-based Lonza yesterday opened the largest gene and cell  therapy production site in the world in Pearland (Texas). The facility has an area of 250,000 square meters and will soon create 200 new jobs–especially scientists and engineers. Lonza has long been focusing on gene therapy as a manufacturer on behalf of third parties, with a sales volume of approximately CHF0.5bn and 24% EBITDA, expected to reach CHF7.5bn and 30% EBITDA.

(Source Lonza)